1-4 of 4
Ann Gils
Close
Sort by
Journal Articles

Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke

Tine Wyseure, Marina Rubio, Frederik Denorme, Sara Martinez de Lizarrondo, Miet Peeters, Ann Gils, Simon F. De Meyer, Denis Vivien, Paul J. Declerck
Journal: Blood
Blood (2015) 125 (8): 1325–1332.
https://doi.org/10.1182/blood-2014-07-588319
Published: 2015
Includes: Supplemental data
Journal Articles

Evaluation of the profibrinolytic properties of an anti-TAFI monoclonal antibody in a mouse thromboembolism model

Ellen Vercauteren, Jan Emmerechts, Miet Peeters, Marc F. Hoylaerts, Paul J. Declerck, Ann Gils
Journal: Blood
Blood (2011) 117 (17): 4615–4622.
https://doi.org/10.1182/blood-2010-08-303677
Published: 2011
Includes: Supplemental data
Journal Articles

The Role of Lysine Residues 42, 43, and 44 in the Activation Peptide Region of TAFI in Its Activation by the Thrombin-Thrombomodulin Complex.

Chengliang Wu, M.Sc., Paul Y Kim, Ph.D., Reg Manuel, Ann Gils, Ph.D., Paul Declerck, Ph.D., Michael E. Nesheim, PhD
Journal: Blood
Blood (2009) 114 (22): 3187.
https://doi.org/10.1182/blood.V114.22.3187.3187
Published: 2009
Journal Articles

Vasculin, a novel vascular protein differentially expressed in human atherogenesis

Ann P. J. J. Bijnens, Ann Gils, Barry Jutten, Birgit C. G. Faber, Sylvia Heeneman, Peter J. E. H. M. Kitslaar, Jan H. M. Tordoir, Carlie J. M. de Vries, Abraham A. Kroon, Mat J. A. P. Daemen, Kitty B. J. M. Cleutjens
Journal: Blood
Blood (2003) 102 (8): 2803–2810.
https://doi.org/10.1182/blood-2003-01-0306
Published: 2003